Pune: Zycov-D, the first vaccine to be approved for use in children in the age group 12-17 in India, will also be available for private sector hospitals throughout the country.
The central supply principle in the ratio of 75:25 for public and private vaccination will still apply to this vaccine too.
Zycov-D will be introduced in the Covid Country Vaccination Program on October 20.
“If there are buyers, up to 25 lakh doses of zycov-D will be available for private sector hospitals every month as the availability of the initial monthly vaccine will be a dose of crore,” NK Arora, Chair of the Covid-19 Center Working Group of the National Technical Advisory Group on Immunization (Ntagi) to Ti on Sunday.
Zycov-D vaccine-free needle, produced by Zydus Cadila, has received authorization of emergency use because it is given to children between the ages of 12 and 17 years in India.
Three dose vaccines must be provided with a gap of 28 days between each dose.
“The biggest obstacle with this vaccine is its slow production.
Initially, the manufacturer can only provide one dose of crore every month,” Arora said.
He, however, added that the private sector did not show much interest in purchasing vaccines after new guidelines on the supply of Covid-19 vaccine in the ratio of 75:25 to apply.
Sanjay Lalwani, Medical Director of Bharati Hospital in Pune, said: “This is a three-dose vaccine, therefore vaccination costs tend to be high, which can have a negative impact on the private sector.”